The Hematology Division at Brigham and Women's Hospital offers a broad range of clinical, research, teaching and administrative services. The clinical staff provides expert, conscientious care in the treatment of patients with blood disorders. Physicians are assisted by nurse practitioners with special expertise in the care of patients with blood disorders, including hemophilia and sickle cell disease. Our clinical staff work closely with laboratory and radiology staff, oncologists, and primary care physicians. From diagnosis to continuing care, patients receive thorough and accessible management of their blood-related illness.
We have a rich history of contributions to hematology going back to the work of Drs. Minot and Murphy, which led to the first treatment for pernicious anemia. Many prominent hematologists trained with us. Dr. David G. Nathan went on to become Physician in Chief at Boston Children's Hospital and then President of the Dana Farber Cancer Institute. Dr. David Rosenthal went on to become director of Harvard University Health Service. In the late 1960s, Dr. William Moloney established treatment and research programs focused on leukemias and lymphomas. In the 1970s, Drs. H. Franklin Bunn and Robert Handin made major advances into the research of hemoglobin function and with platelet biology and blood coagulation disorders. Dr. Thomas Stossel was named American Cancer Society Clinical Research Professor in 1987, then was elected to the National Academy of Science in 1997. Nancy Berliner, MD, a distinguished physician and faculty member at Yale Medical School, joined the clinical staff in 2007 and assumed the position of Chief of the Division. She will serve as the President of the American Society of Hematology in 2009. The Division's partners include Dana Farber Cancer Institute, Children's Hospital Boston and Harvard Medical School.
Send Feedback to: 
